2026 NPPES data Oncology Registered Nurse NPI 1669830451 FNP
Verify on CMS →

VALENTINA RUVALCABA, FNP

Oncology Registered Nurse in CHULA VISTA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
578
Medicare Part D claims · 107 beneficiaries · Oncology Registered Nurse avg: 555
Generic prescribing
74%
generic claims · 26% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$613.44
23 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

VALENTINA RUVALCABA, FNP filed 578 Medicare Part D claims in 2023 as a Oncology Registered Nurse in CHULA VISTA, California, prescribing 74% generic.

578
Part D claims, 2023
74%
generic prescribing
$613.44
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

VALENTINA RUVALCABA, FNP's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

578 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about VALENTINA RUVALCABA, FNP?

Quality data not reported

NPI registry status

Active

Issued 02/08/2016

NPI 1669830451

Primary specialty

Oncology Registered Nurse

Niche

857 US NPIs in this specialty

Medicare Part D claims

578 4% vs specialty avg

2023 prescription claims

Specialty avg: 555

Specialty distribution in California

How Oncology Registered Nurse compares to other specialties among California providers

California providers

Oncology Registered Nurse share within California

1. Oncology Registered Nurse42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Registered Nurse share within California

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Registered Nurse (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Registered Nurse ABMS/AOA estimate

Est. board-certified rate (Oncology Registered Nurse) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Registered Nurse) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

VALENTINA RUVALCABA, FNP appears in the CMS NPPES registry as a Oncology Registered Nurse provider holding FNP credentials at 769 MEDICAL CENTER CT, CHULA VISTA, CA, 91911, with a listed phone of (619) 482-8430. NPI 1669830451 was issued on 02/08/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RUVALCABA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 578 prescription claims written by this provider, covering 107 Medicare beneficiaries and totaling roughly $2.0 million in drug spend, split 26% brand-name and 74% generic by claim count, with an opioid prescribing rate of 4.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oncology Registered Nurse is a narrow specialty nationwide, with 857 enrolled providers across 50 states and an average of 555 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

769 MEDICAL CENTER CT
CHULA VISTA, CA 91911

Provider Details

NPI 1669830451
Specialty Oncology Registered Nurse
Credentials FNP
Gender Female
NPI Issued 02/08/2016

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for VALENTINA RUVALCABA, FNP. Source: openpaymentsdata.cms.gov.

Total received

$613

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to VALENTINA RUVALCABA, FNP. To verify VALENTINA RUVALCABA, FNP's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

VALENTINA RUVALCABA, FNP — brand share 26.0%
Specialty average (est.)

26% brand-name claims vs 74% generic, on 578 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

578
Total Claims
$2.0M
Total Drug Cost
107
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
858
Total Day Supply
24,542
Brand vs Generic
26% brand / 74% generic
Brand Drug Cost
$1.8M
Generic Drug Cost
$140K
Opioid Claims
23 (4.0% rate)

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
2.05
Gender Split
77% female / 23% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What VALENTINA RUVALCABA, FNP prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
154
Ibrance
Palbociclib
44
Alendronate Sodium
42
Bicalutamide
22
Anastrozole
21
Dexamethasone
21
Hydroxyurea
20
Xarelto
Rivaroxaban
17
Tamsulosin Hcl
16
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oncology Registered Nurse Overview

How VALENTINA RUVALCABA, FNP fits within the Oncology Registered Nurse landscape nationally.

857
Oncology Registered Nurse Providers in US
50
States with Oncology Registered Nurse
555
Avg Claims per Provider

VALENTINA RUVALCABA, FNP's 578 claims are above the specialty average of 555.

Nearby Oncology Registered Nurse Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as RUVALCABA.

Compare Oncology Registered Nurse nationally: see state-by-state distribution →

Frequently Asked Questions

What is VALENTINA RUVALCABA, FNP's specialty?
VALENTINA RUVALCABA, FNP specializes in Oncology Registered Nurse and practices in CHULA VISTA, California. Credentials: FNP.
How much does VALENTINA RUVALCABA, FNP prescribe under Medicare Part D?
In 2023, VALENTINA RUVALCABA, FNP wrote 578 Medicare Part D claims totaling $2.0M in drug costs for 107 beneficiaries.
Where is VALENTINA RUVALCABA, FNP located?
VALENTINA RUVALCABA, FNP is located at 769 MEDICAL CENTER CT, CHULA VISTA, CA, 91911. Phone: (619) 482-8430.
What is VALENTINA RUVALCABA, FNP's NPI number?
VALENTINA RUVALCABA, FNP's National Provider Identifier (NPI) is 1669830451, issued on 02/08/2016.
Does VALENTINA RUVALCABA, FNP prescribe more brand-name or generic drugs?
VALENTINA RUVALCABA, FNP's prescribing is 26% brand-name and 74% generic drugs by claim count, with $1.8M in brand drug costs.
Does VALENTINA RUVALCABA, FNP prescribe opioids?
Yes, VALENTINA RUVALCABA, FNP had 23 opioid claims in 2023 with an opioid prescribing rate of 4.0%.
How many Oncology Registered Nurse providers are there in the US?
There are 857 Oncology Registered Nurse providers across 50 states in the US. The average Oncology Registered Nurse provider writes 555 Medicare Part D claims per year.
What drugs does VALENTINA RUVALCABA, FNP prescribe most often?
Based on 2023 Medicare Part D data, VALENTINA RUVALCABA, FNP's most frequently prescribed drugs include Letrozole, Ibrance, Alendronate Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does VALENTINA RUVALCABA, FNP accept Medicare?
VALENTINA RUVALCABA, FNP appears in CMS Medicare data with 578 Part D claims and 107 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify VALENTINA RUVALCABA, FNP's credentials?
VALENTINA RUVALCABA, FNP's NPI is 1669830451 with credentials FNP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology